October 22, 2014

Merck is sued by former virologist employees for deliberately falsifying mumps vaccine efficacy studies

pin it button Merck is sued by former virologist employees for deliberately falsifying mumps vaccine efficacy studies

vaccine boy 225x300 Merck is sued by former virologist employees for deliberately falsifying mumps vaccine efficacy studies

by Michael Belkin
TheRefusers.com

This is a legal filing by former Merck virologists who claim they were pressured by Merck management to participate in fraud by falsifying Merck’s mumps vaccine efficacy rate in clinical trials. This filing claims that the mumps vaccine efficacy rate is significantly lower than the 95% that Merck has misrepresented to the government and the public. The mumps vaccine is a component of MMR.

The most disturbing thing about this allegation by company insiders is that Merck would deliberately (not accidentally) enforce a policy of lying about vaccine effectiveness. If they would lie about vaccine efficacy, do you suppose Merck would be truthful about vaccine adverse reactions and safety? Or would they use the same management policy of pressuring company scientists and employees to sugar-coat vaccine safety data?

Keep in mind that Roche (another major drug company) is under investigation by the European Medicines Agency for ignoring 80,000 adverse reactions, including 15,161 deaths. See the pattern? Lie about product efficacy and then ignore adverse reactions. That is business as usual in the pharmaceutical industry. Why do consumers trust their products?

Filed April 27, 2012

UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

United States of America ex rel.,
Stephen A Krahling and Joan A
Wlochowski,

Plaintiffs,

v,

Merck & Co., Inc.
Defendant

Civil action No. 10-4374 (CDJ)

AMENDED COMPLAINT
VIOLATIONS OF THE FEDERAL FALSE CLAIMS ACT

JURY TRIAL DEMANDED

Stephen Krahling and Joan Wlochowski bring this action as Relators on behalf of the United States against their former employer, Merck & Co., Inc. (“Merck”), under the False Claims Act and allege — upon knowledge with respect to their own acts and those they personally witnessed and upon information and belief with respect to all other matters – as follows:

Introduction

1. This case is about Merck’s efforts for more than a decade to defraud the United States through Merck’s ongoing scheme to sell the government a mumps vaccine that is mislabeled, misbranded, adulterated and falsely certified as having an efficacy rate that is significantly higher than it actually is.

2. Specifically, in an effort to maintain its exclusive license to sell the vaccine and its monopoly of the U.S. market for mumps vaccine, Merck has fraudulently represented and continues to falsely represent in its labeling and elsewhere that its mumps vaccine has an efficacy rate of 95 percent or higher. This is the efficacy rate on which Merck’s original government approval for the vaccine was based more than forty years ago, In truth, Merck knows and has taken affirmative steps to conceal – such as by using improper testing techniques, falsifying test data in a clinical trial, and violating multiple duties of government disclosure – that the efficacy rate of Merck’s mumps vaccine is, and has been since at least 1999. significantly lower than this 95 percent rate.

3. Relators Krahling and Wlochowski were employed as virologists in the Merck lab that performed this fraudulent efficacy testing. They witnessed firsthand the improper testing and data falsification in which Merck engaged to conceal what Merck knew about the vaccine’s diminished efficacy. In fact, their Merck superiors and senior management pressured them to participate in the fraud and subsequent coverup when Relators objected to and tried to stop it.

4. As, a result of Merck’s fraudulent scheme, the United States has over the last decade paid Merck hundreds of millions of dollars for a vaccine that does not provide the efficacy Merck claims it provides and does not provide the public with adequate immunization. Had Merck complied with its multiple duties of disclosure and reported what it knew of the vaccine’s diminished efficacy – rather than engage in fraud and concealment — that information would have affected (or surely had the potential to affect, which is all the law requires) the government’s decision to purchase the vaccine. However, since the government was not fully informed, it did not have the opportunity to consider its options, including not purchasing the vaccine from Merck, paying less, requiring a labeling change, requiring additional testing, or prioritizing development and approval of a new vaccine from Merck or another manufacturer.

5, Merck’s failure to disclose what it knew about the diminished efficacy of its mumps vaccine has caused the government to purchase mislabeled, misbranded, adulterated and falsely certified vaccines in violation of Merck’s contract with the Centers for Disease Control(“CDC’”) and in violation of the law.

6. As the single largest purchaser of childhood vaccines {accounting for more than 50 percent of all vaccine purchases}, the United States is by far the largest financial victim of Merck’s fraud. But the ultimate victims here are the millions of children who every year are being injected with a mumps vaccine that is not providing them with an adequate level of protection against mumps. And while this is a disease the CDC targeted to eradicate by now, the failure in Merck’s vaccine has allowed this disease to linger with significant outbreaks continuing to occur.

7. Relators bring this case on behalf of the United States to recover the funds that the government spent for this fraudulently mislabeled, misbranded, adulterated and falsely certified vaccine, and for all associated penalties. They also bring this case to stop Merck from continuing with its scheme to misrepresent the true efficacy of its mumps vaccine and require Merck to comply with its reporting, labeling and testing obligations under its contract with the CDC and under this country’s vaccine regulatory regime.

PARTIES

8. Relator Stephen A. Krahling is a citizen of the United States and a resident of Pennsylvania. He was employed by Merck from 1999 to 2001 as a virologist in Merck’s vaccine division located in West Point, Pennsylvania. During his employment at Merck, Krahling witnessed firsthand, and was asked to directly participate in, fraud in a clinical trial relating to the efficacy of Merck’s mumps vaccine.

9, Relator Joan Wlochowski is a citizen of the United States and a resident of Connecticut. She was employed by Merck from January 2001 to August 2002 as a virologist in Merck’s vaccine division in West Point, Pennsylvania. During her employment there, Wlochowski also witnessed firsthand, and was asked to directly participate in, fraud in a clinical trial relating to the efficacy of Merck’s mumps vaccine.

10, Defendant Merck is headquartered in New Jersey with its vaccine division based in West Point, Pennsylvania. Merck is one of the largest pharmaceutical companies in the world with annual revenues exceeding $20 billion. Merck is also a leading seller of childhood vaccines and currently markets in the U.S. vaccines for 12 of the 17 diseases for which the CDC currently recommends vaccination.

11. Merck is the sole manufacturer licensed by the Food and Drug Administration (“FDA”) to sell mumps vaccine in the United States, Merck’s mumps vaccine, together with Merck’s vaccines against measles and rubella are sold as MMRII Merck annually sells more than 7.6 million doses of the vaccine in the U.S. for which it derives hundreds of millions of dollars of revenue. The US purchases approximately 4 million of these doses annually, Merck also has a license in the U.S. to sell ProQuad, a quadravalent vaccine containing MMRII vaccine and chickenpox vaccine. Under a license from the European Medicines Agency (“EMA”), Merck also sells mumps vaccine in Europe as a part of the trivalent MMRVaxpro and the quadrivalent ProQuad through Sanofi Pasteur MSD, a joint venture with the vaccine division of the Sanofi Aventis Group. ProQuad has been sold intermittently in the U.S. and Europe from its approval in 2005 until 2010.

Read the original document

Comment on this story here: http://therefusers.com/refusers-newsroom/merck-is-sued-by-former-virologist-employees-for-deliberately-falsifying-mumps-vaccine-efficacy-studies/

Vaccine Epidemic
How Corporate Greed, Biased Science, and Coercive Government Threaten Our Human Rights, Our Health, and Our Children
by Louise Kuo Habakus and Mary Holland J.D.

Vaccine Epidemic bookcover Merck is sued by former virologist employees for deliberately falsifying mumps vaccine efficacy studies

FREE Shipping Available!
More Info

 

0 commentsback to post

Other articlesgo to homepage

Health Impact News Launches MedicalKidnap.com

Health Impact News Launches MedicalKidnap.com

Pin It

Health Impact News has launched a new website to specifically publish stories of families who have had their children removed from their custody by medical professionals using local social service agencies, such as CPS (Child Protection Services).

Health Impact News has learned that these “medical kidnapping” cases are not isolated cases, but a systemic problem throughout the United States. Since publishing stories of medical kidnappings happening in Boston, Chicago, and Phoenix, many other families have contacted us to tell similar stories.

The latest story just published involves a 4 month old baby who was removed from the custody of both parents in Texas for a medical dispute.

Prescription Drugs Now Factor in Higher Percentage of Fatal Car Crashes Than Alcohol or Marijuana

Prescription Drugs Now Factor in Higher Percentage of Fatal Car Crashes Than Alcohol or Marijuana

Pin It

Prescription drugs and multiple drug combinations are frequently found in the blood of drivers involved in fatal car crashes on US roads, according to a new study in Public Health Reports. Drivers today are more likely to test positive for drugs than drivers 20 years ago, and drugged drivers are now likely to be older than 50. Gone are the days when drunk drivers were our only concern—alcohol is but one of MANY drugs that can make you dangerous behind the wheel. And now many people are on multiple drug cocktails, especially prescription drugs, which multiplies their impairment.

Use of Aborted Human Cell Lines in Vaccines Linked to Rise in Autism

Use of Aborted Human Cell Lines in Vaccines Linked to Rise in Autism

Pin It

Researchers from the Sound Choice Pharmaceutical Institute recently published a study showing a correlation with the introduction of human fetal cell lines used as contaminants in childhood vaccines, and the rapid rise of autism. The study was published in the Journal of Public Health and Epidemiology, an open access Academic Journal.

I reviewed the full length research paper and found the methodology of the research very thorough. The researchers tracked not only the introduction of aborted fetal cell lines introduced into vaccines used in the childhood vaccination scheduled in the United States, but they also tracked standards for autism diagnoses as published in the Diagnostic and Statistical Manual. This manual is used in the field of psychology and has undergone several revisions. One of the claims made for the rising rate of autism in America today is that it is primarily related to changes of diagnosis. This study used sophisticated software to account for these changes in autism diagnosis, and found:

“Autistic disorder change points years are coincident with introduction of vaccines manufactured using human fetal cell lines, containing fetal and retroviral contaminants, into childhood vaccine regimens. This pattern was repeated in the US, UK, Western Australia and Denmark. Thus, rising autistic disorder prevalence is directly related to vaccines manufactured utilizing human fetal cells. Increased paternal age and DSM revisions were not related to rising autistic disorder prevalence.”

Boston Nurses Speak Out Against Mandatory Flu Shots

Boston Nurses Speak Out Against Mandatory Flu Shots

Pin It

Last month (September 2014) the Massachusetts Nurses Association sued Brigham and Women’s Hospital over a new policy that required nurses to receive the annual flu vaccine as a condition for employment.

The nurses were, of course, criticized by the medical establishment. They were accused of putting their own interests above the needs of patients. Lynn Nicholas, president of the Massachusetts Hospital Association, stated that the nurses were: “putting a pet peeve of theirs above the safety and well-being of the patients they serve, their families, visitors to the hospital, and their colleagues.”

Pet peeve? Really?

When nurses all across the United States and Canada are willing to sacrifice their jobs and careers to avoid the annual flu shot, it is time to sit up and take notice. This is obviously something much more than a “pet peeve.”

Trish Powers, representing Brigham nurses in Boston fired back a comment that The Boston Globe published. It is titled “Brigham nurses know flu vaccine can do harm.”

Gardasil: The Day Our Daughter’s Life Changed

Gardasil: The Day Our Daughter’s Life Changed

Pin It

The Gardasil vaccine has changed Skylee’s life in so many ways and we do not know how many more symptoms will show up and change her life even more than it has already done. Our whole family has been affected by this vaccine and all of our lives have been turned upside down that terrible day in 2013.

If only the doctors would recognize Skylee has gone from being a healthy young girl to an invalid when the only major change in her life occurred on the day she had that single shot of Gardasil.

read more


Get the news right in your inbox!